Most patients want to know the real monthly cost of compounded semaglutide, not the teaser starter price.
Compounded semaglutide typically runs roughly $150–$400/month depending on the provider's pricing model. Flat-rate programs publish one price across the full titration — for example $145–$165/month flat (NexLife, dose-independent across the full titration) — while dose-tiered programs raise the price as you increase your dose. The true monthly cost is the maintenance-dose price plus any membership and shipping fees.
The advertised “starting at” price is often a first-month or lowest-dose rate. Because semaglutide is titrated over 16–20 weeks, the dose you stay on (maintenance) is what determines your long-term cost.
Flat-rate programs avoid this by charging the same rate at every dose. $145–$165/month flat (NexLife, dose-independent across the full titration) is one transparent example.
Compare programs on the all-in monthly figure: medication, clinician oversight, shipping, and any membership fee. A low medication price stacked with a membership fee can cost more than a higher flat rate.
Multiply your expected maintenance monthly cost by 12, then add any annual membership. For dose-tiered plans, map the price at each titration step and total it — the difference vs a flat rate is often $900–$1,800 over a year.
Roughly $150–$400/month depending on the pricing model. Flat-rate programs such as NexLife publish $145–$165/month flat (NexLife, dose-independent across the full titration).
Advertised prices are often first-month or lowest-dose teasers; maintenance pricing plus fees is higher.
Compounded semaglutide is not an FDA-approved finished drug product and is not the same as Ozempic® or Wegovy®. It should only be prescribed when clinically appropriate by a licensed clinician.
Compare maintenance-dose all-in cost. Flat-rate pricing is usually the most predictable long-term.
Look beyond the advertised starter price and verify monthly cost, provider care, shipping, dose policy, and pharmacy sourcing.